4-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching
November 22, 2019 18:01 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Nov. 22, 2019 (GLOBE NEWSWIRE) -- Hagens Berman urges Myriad Genetics, Inc. (NASDAQ: MYGN) investors who have suffered losses in excess of $50,000 to submit their losses now or...
9-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching
November 17, 2019 08:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Nov. 17, 2019 (GLOBE NEWSWIRE) -- Hagens Berman urges Myriad Genetics, Inc. (NASDAQ: MYGN) investors who have suffered losses in excess of $50,000 to submit their losses now or...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching
November 12, 2019 20:07 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Hagens Berman urges Myriad Genetics, Inc. (NASDAQ: MYGN) investors who have suffered losses in excess of $50,000 to submit their losses now or...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Myriad Genetics (MYGN) Investors of Securities Class Action, Encourages Investors Who Suffered Significant Losses to Contact the Firm
November 04, 2019 20:01 ET
|
Hagens Berman Sobol Shapiro LLP
Class-action law firm urges MYGN investors who have suffered losses of $50K+ to submit your loss now to learn if they qualify to recover their investment losses. SAN FRANCISCO, Nov. 04, 2019 ...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Myriad Genetics (MYGN) Investors of Securities Class Action: Investors Who Suffered Significant Losses are Encouraged to Contact the Firm
October 29, 2019 20:04 ET
|
Hagens Berman Sobol Shapiro LLP
Class-action law firm urges MYGN investors who have suffered losses of $50K+ to submit your loss now to learn if they qualify to recover their investment losses. SAN FRANCISCO, Oct. 29, 2019 (GLOBE...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, REMINDS MYGN INVESTORS OF CLASS ACTION: Myriad Genetics (MYGN) Investors Who Suffered Significant Losses are Encouraged to Contact the Firm
October 23, 2019 20:10 ET
|
Hagens Berman Sobol Shapiro LLP
Class-action law firm urges MYGN investors who have suffered losses of $50K+ to submit your loss now to learn if they qualify to recover their investment losses. SAN FRANCISCO, Oct. 23, 2019 (GLOBE...
MYGN SHAREHOLDER REMINDER: Hagens Berman Reminds Myriad Genetics (MYGN) Investors of Securities Fraud Lawsuit, Encourages Investors Who Lost $50,000+ to Contact the Firm
October 16, 2019 20:04 ET
|
Hagens Berman Sobol Shapiro LLP
Class-action law firm urges MYGN investors who have suffered losses of $50K+ to submit your loss now to learn if they qualify to recover their investment losses. SAN FRANCISCO, Oct. 16, 2019 (GLOBE...
MYGN CLASS ACTION REMINDER: Hagens Berman Reminds Myriad Genetics (MYGN) Investors of Securities Fraud Lawsuit, Encourages Investors Who Lost $50,000+ to Contact the Firm
October 07, 2019 19:48 ET
|
Hagens Berman Sobol Shapiro LLP
Class-action law firm urges MYGN investors who have suffered losses of $50,000+ to learn their shareholder rights SAN FRANCISCO, Oct. 07, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in...
MYGN CLASS ACTION REMINDER: Hagens Berman Reminds Investors in Myriad Genetics (MYGN) of Securities Fraud Lawsuit
October 01, 2019 20:04 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Myriad Genetics, Inc. (NASDAQ: MYGN) of the pending securities class action and urges MYGN investors who have...
MYGN INVESTIGATION REMINDER: Hagens Berman Reminds Myriad Genetics (MYGN) Investors of the Firm’s Ongoing Investigation of Possible Disclosure Violations
September 23, 2019 20:02 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Myriad Genetics, Inc. (NASDAQ: MYGN) of the firm’s investigation of possible disclosure violations. RELEVANT...